The Oligonucleotide Synthesis Market Is Expected to Reach USD 1,918.6 Million at a CAGR of 10.1% by 2020 According to, 'Oligonucleotide Synthesis Market 2015 - Global Forecast to 2020'

DUBLIN, December 18, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/4t725r/oligonucleotide) has announced the addition of the "Oligonucleotide Synthesis Market 2015 - Global Forecast to 2020" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Growth in the market is driven by rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. 

The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, and genetic engineering and synthetic biology also play a vital role in driving the growth of this market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market. 

The oligonucleotide synthesis market in this report is segmented on the basis of products and services, applications, end users, and regions. Based on product and services, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotide segment is further bifurcated on the basis of products and services. On the basis of product, the synthesized oligonucleotide segment is categorized into primers, probes, large-scale synthesis oligos, and intermediate-scale synthesis oligos; whereas, by service, the synthesized oligonucleotide segment is categorized into custom oligos and predesigned oligos. 

The synthesized oligonucleotides segment is expected to dominate the market by accounting for the largest share in 2015, and it is also expected to experience the highest growth rate during the forecast period. High growth in this segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics. The rising demand for custom oligos also contributes to the growth of the synthesized oligonucleotides market. 

On the basis of applications, the oligonucleotide synthesis market is categorized into research, diagnostic, and therapeutic applications. The research applications include PCR, qPCR, sequencing, gene synthesis, and other research applications (nucleic acid-based testing, isothermal nucleic acid technology, binding studies, gel shift assays, and fluorescence in situ hybridization (FISH)). The therapeutic applications segment includes RNAi, DNA/antisense oligos, nucleic acid aptamers, and other therapeutic applications (immunostimulatory agents in immunotherapy applications). 

The research applications segment is expected to dominate the market; however, the diagnostic applications segment is expected to grow at the highest CAGR during the forecast period. High growth of this segment is attributed to the rapidly growing fields of molecular diagnostics (MDx), emerging technologies such as DNA sequencing and next-generation sequencing (NGS). 

Key Topics Covered: 

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Oligonucleotide Synthesis Market, By Products & Services

8 Oligonucleotide Synthesis Market, By Application

9 Oligonucleotide Synthesis Market, By End User

10 Regional Analysis

11 Competitive Landscape

12 Company Profiles

- Agilent Technologies, Inc. 
- Bioautomation Corporation 
- Biosearch Technologies, Inc. 
- Eurofins Genomics 
- Eurogentec S.A. 
- Gen9, Inc. 
- Genedesign, Inc. 
- General Electric Company (Ge) 
- Genscript Usa Inc. 
- Integrated Dna Technologies, Inc. (Idt) 
- Nitto Denko Avecia Inc. (Avecia) 
- Sigma-Aldrich Corporation 
- Thermo Fisher Scientific, Inc. 
- Trilink Biotechnologies, Inc. 

For more information visit http://www.researchandmarkets.com/research/4t725r/oligonucleotide

Research and Markets: 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net

SOURCE Research and Markets